-
Prostate cancer drug combo cuts risk of death by more than 40%
20 Oct 2025 08:20 GMT
… findings from the trial led by Cedars- … the European Society for Medical Oncology Congress (ESMO … plus leuprolide (the combination group), leuprolide (the leuprolide-alone … Drug Administration (FDA) and listed in National Comprehensive Cancer Network treatment …
-
<![CDATA[ Enzalutamide Plus Leuprolide Yields OS Benefit in High-Risk, Biochemically Recurrent Prostate Cancer,]]>
19 Oct 2025 17:12 GMT
… (OS) vs leuprolide acetate alone for the treatment of patients with … from the phase 3 EMBARK trial (NCT02319837) presented during the … The New England Journal of Medicine.1,2
At 8 … serious treatment emergent adverse events (TEAEs) related to the study drug …
-
XTANDI® Plus Leuprolide Reduced Risk of Death by 40% vs Leuprolide Alone in Men with a Type of Advanced Prostate Cancer
19 Oct 2025 09:15 GMT
… trial were published in the New England Journal of Medicine … in eight randomized clinical trials. In a study … receiving placebo plus leuprolide. Permanent treatment discontinuation due to … parties.
Information about pharmaceutical products (including products …
-
This is the new 'wonder' ingredient found in everything from weight-loss jabs to A-list treatments and 'bio-enhancement'... but as the 'Wild West' market thrives, our experts reveal the warnings you can't ignore
14 Oct 2025 11:10 GMT
… tumour (such as goserelin or leuprolide for prostate and some breast … very different from those in medical treatments. Beauty peptides are tiny, … success of peptides in clinical trials is being exploited by … did it properly under a doctor and it worked for me …
-
Understanding Preferences, Needs, and Expectations for Pharmaceutical Treatment of Symptomatic Uterine Fibroids Based on Surveys of Healthcare Providers and Patients
08 Oct 2025 23:07 GMT
… patient preferences for attributes of pharmaceutical treatments indicated for symptomatic UF in … ), “drug effects on BMD” (RI: 154 vs 107), and “impact of medication … . Patient preferences for elagolix and leuprolide for treating endometriosis-related pain …
-
FDA news recap in urologic oncology for Q3 2025
03 Oct 2025 19:18 GMT
… specific mortality.2
FDA approves 3-month formulation of leuprolide mesylate for … between trial and commercial-scale products. Telix said it plans immediate remediation … 4. Foresee Pharmaceuticals announces FDA approval of CAMCEVI for the treatment of advanced …
-
<![CDATA[EMBARK data indicate large OS benefit with enzalutamide/ADT in prostate cancer]]>
19 Oct 2025 15:02 GMT
… Medicine.
Previously published data from the EMBARK trial indicated that enzalutamide plus leuprolide … incidence of serious treatment-emergent AEs related to study drug was below … 10% in all 3 treatment arms.
In …
-
Foresee Pharmaceuticals Announces FDA Approval Of CAMCEVI ETM For The Treatment Of Advanced Prostate Cancer
29 Aug 2025 04:55 GMT
… PRNewswire/ -- Foresee Pharmaceuticals (6576), ("Foresee… Drug Administration (FDA) has approved the New Drug Application (NDA) for CAMCEVI ETM (leuprolide … enrolled, in which treatment with CAMCEVI ETM … Phase 3 clinical trial in premenopausal breast …
-
<![CDATA[Stephen Freedland, MD, highlights OS data from EMBARK]]>
19 Oct 2025 10:14 GMT
… combination of enzalutamide plus leuprolide reduced the risk of … death by 17% vs leuprolide alone, although this … reported that enzalutamide plus leuprolide and enzalutamide monotherapy extended … 2025 European Society for Medical Oncology Congress. October 17 …
-
Advances of Drug-Loaded Microsphere Technology for Targeted Immunotherapy Against Prostate Cancer
19 Sep 2025 16:43 GMT
… resists conventional treatments. Microcatheter-assisted drug-loaded microspheres … therapy (ADT) drugs, such as leuprolide and goserelin, … as collaboration across clinical medicine, data science, … doi:10.3390/pharmaceutics14020359.
10. Nicoletti R, …
About
© 1995-2025